Urinary L-FABP levels were also significantly increased in the progression and CKD groups compared with non-progression and CKD subjects with DM [<i>P</i> = 0.02, <i>P</i> < 0.00001, respectively]. This evidence concerns the gene FABP1 and chronic kidney disease.